Consideration is given to the influence of BCR-ABLp210 expression on the behavior of CML leukemia stem cells (LSCs) that give rise to the chronic phase of disease, and why the behavior of these cells is very different to that of HSCs. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.